"Dabrafenib and Trametinib in Circulating Free DNA BRAFV600 Mutated Metastatic Melanoma Patients: a Prospective Phase II, Open Label, Multicentre Study - (Bioliquid TAILOR Study - BIOTAILOR)"
- Status
- WITHDRAWN
- Phase
- PHASE2
Clinical Trials Related to Melanoma
Related studies linked through entity extraction aliases.
A Study to Compare Nivolumab Administered Subcutaneously vs Intravenous in Melanoma Participants Following Complete Resection
- Status
- COMPLETED
- Phase
- PHASE3
CD8+ T Cell Imaging During Pre-surgery Immunotherapy in People With Melanoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Phase II Trial of Neoadjuvant and Adjuvant IO102-IO103 and Pembrolizumab KEYTRUDA® in Patients With Resectable Tumors
- Status
- RECRUITING
- Phase
- PHASE2
XP-102 and XP-102 in Combination With Trametinib in Advanced Solid Tumor Patients With a BRAF V600 Mutation
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Adjuvant Encorafenib and Binimetinib in High-risk Stage II Melanoma With a BRAF Mutation.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Novel RNA-lipid Particle (RNA-LP) Vaccine for Anti-PD-1 Antibody Therapy Sensitization
- Status
- RECRUITING
- Phase
- PHASE1
HL-085+Vemurafenib to Treat Advanced Melanoma Patients With BRAF V600E/K Mutation
- Status
- UNKNOWN
- Phase
- PHASE2
Comparative Effectiveness of Targeted Therapies in BRAF Positive Metastatic Melanoma in the US
- Status
- COMPLETED
- Phase
- N/A
Glycan Mediated Immune Regulation With a Bi-Sialidase Fusion Protein (GLIMMER-01)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of HFB200301 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Personalized Immune Cell Therapy Targeting Neoantigen of Malignant Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
A Trial of Intratumoural Tigilanol Tiglate in Adult Participants With Stage IIIB to IV M1c Melanoma
- Status
- TERMINATED
- Phase
- PHASE2
Ex VIvo DEtermiNed Cancer Therapy
- Status
- RECRUITING
- Phase
- N/A
Immunotherapy and Carbon Ion Radiotherapy In Solid Cancers With Stable Disease
- Status
- RECRUITING
- Phase
- PHASE2
A Study of HFB301001 in Adult Patients With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Video Education With Result Dependent dIsclosure
- Status
- RECRUITING
- Phase
- NA
Investigating the Diagnostic Potential of Tear Proteins in Cancer - A Pilot Study
- Status
- UNKNOWN
- Phase
- N/A
Oncolytic Adenovirus TILT-123 and Avelumab for Treatment of Solid Tumors Refractory to or Progressing After Anti-PD(L)1
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
HL-085 in NRAS-mutated Advanced Melanoma
- Status
- COMPLETED
- Phase
- PHASE2